<DOC>
	<DOCNO>NCT00151814</DOCNO>
	<brief_summary>Determine single dose pharmacokinetic parameter olmesartan pediatric patient hypertension age 12 month - 16 year</brief_summary>
	<brief_title>Olmesartan Pediatric Pharmacokinetic ( PK ) Study</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Olmesartan</mesh_term>
	<mesh_term>Olmesartan Medoxomil</mesh_term>
	<criteria>Age 12 month 16 year inclusive Signed parental/guardian informed consent assent subject Current treatment hypertension , , currently treat hypertension , systolic blood pressure ( SBP ) great equal 95th percentile gender heightforage , , currently treat hypertension , systolic blood pressure diastolic blood pressure great equal 90th percentile gender heightforage diabetic family history hypertension Glomerular filtration rate ( GFR ) great equal 30 mL/min/1.73 m2 , estimate use Schwartz equation Sexually active female childbearing potential must practice acceptable method birth control Negative serum betahuman chorionic gonadotropin screen admission ( female childbearing potential ) Clinically significant cardiac , gastrointestinal , hematologic , hepatic hepatobiliary , neurologic , pulmonary ( except asthma ) disorder History severe symptomatic hypertension associate stroke , seizure , encephalopathy , significant neurologic finding within 1 year prior screen Current treatment 2 antihypertensive medication Secondary hypertension uncorrected coarctation aorta , bilateral renal artery stenosis , unilateral renal artery stenosis single kidney Serum albumin &lt; 2.5 g/dL Major organ bone marrow transplantation except prior kidney transplantation least 6 month stable renal function meeting inclusion criterion</criteria>
	<gender>All</gender>
	<minimum_age>12 Months</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>April 2010</verification_date>
	<keyword>Olmesartan PK child</keyword>
</DOC>